CS logo
small CS logo
University of Michigan Hemophilia and Coagulation Disorders

Ann Arbor, Michigan, United States

About University of Michigan Hemophilia and Coagulation Disorders


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Michigan Hemophilia and Coagulation Disorders


During the past decade, University of Michigan Hemophilia and Coagulation Disorders conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Hemophilia and Coagulation Disorders" #1 collaborator was "Takeda" with 2 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator and "Octapharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at University of Michigan Hemophilia and Coagulation Disorders


According to Clinical.Site data, the most researched conditions in "University of Michigan Hemophilia and Coagulation Disorders" are "Haemophilia" (1 trials), "Haemophilia A Without Inhibitor" (1 trials), "Haemophilia B Without Inhibitor" (1 trials), "Hemophilia" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "University of Michigan Hemophilia and Coagulation Disorders" in a lesser frequency.

Clinical Trials Intervention Types at University of Michigan Hemophilia and Coagulation Disorders


Clinical Trials Genders at University of Michigan Hemophilia and Coagulation Disorders


The vast majority of trials in "University of Michigan Hemophilia and Coagulation Disorders" are 2 trials for "All" genders.

Clinical Trials Status at University of Michigan Hemophilia and Coagulation Disorders


Currently, there are NaN active trials in "University of Michigan Hemophilia and Coagulation Disorders". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Michigan Hemophilia and Coagulation Disorders, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Michigan Hemophilia and Coagulation Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".